dian clock at the end of the nocturnal domain. This role would be similar to G2/M cyclin-dependent kinase (CDK) control of progression from S phase in the cell cycle (Hayles et al., 1994). Our results provide compelling evidence for such a checkpoint at the night-to-day transition and suggest that passage through this checkpoint is dependent upon clock-controlled activation of PKG-II. If PKG-II activation fails to occur during this restricted interval, the clock rapidly resets to an earlier state and must repeat the late-night domain. Extended PKG inhibition increases in the magnitude of the delay by quantal increments, and constant inhibition of PKG-II disrupts SCN circadian rhythmicity. Finally, mechanistic studies indicate that PKG may act on the positive arm of the core molecular clockworks. Thus, increased activity of our contention that the lower band is not PKG-II, but an unidentified protein that interacts with our primary antibody.
Dynamic Phase Resetting by PKG Inhibition
In our system, measurable phase delays could result from either (1) the clock stalling at the time of treatment and remaining at that point until the treatment is removed or (2) immediate clock resetting to an earlier time. To distinguish between these possibilities, we evaluated the effect of various durations of PKG inhibition and effects of double pulses of inhibitors. First, the PKG inhibitor KT5823 (1.0 M) was applied for different durations at CT 22, the time of maximal sensitivity to phase shifting (Tischkau et al., 2003b) . KT5823 was used for these experiments rather than PKG-II ␣ODN because the duration of antisense treatment required for an effect is much longer than that for KT5823 (2 hr versus 15 min). Application of KT5823 for 0.25, 1, 2, or 3 hr beginning at CT 22 induced ‫5.3ف‬ hr phase delay in the electrical activity rhythm that was stable over two circadian cycles ( Figure 3A) . However, exposure to KT5823 for 3.5 (n ϭ 3) Figure 5D ). We conclude that suppression of the circadian rhythm was specific to PKG-II ␣ODN treatment and the concomitant reduction of PKG-II expression.
To evaluate whether the ␣ODN-induced inhibition of circadian rhythmicity is reversible, ␣ODN to PKG-I or -II was applied to SCN slices for 22 hr from CT 2 to CT 24/0. Single-unit activity on the following day, after removal of the treatment, revealed the reemergence of the spontaneous electrical activity rhythm with a peak at CT 10.19 Ϯ 0.16, (n ϭ 4), a phase delay of Ϫ3.47 hr ( Figure  5E ). These data indicate that PKG-II only, and not PKG-I␤, is required for the electrical activity rhythm of SCN neurons and that the sensitive period at the end of subjective night is the only domain that is sensitive to PKG-II inhibition. However, when PKG-II activation is blocked during this sensitive period, either during long-term ex- Spontaneous firing rates of individual neurons were grouped into Under these conditions, the SCN generates stable, near 24 hr oscilla-2 hr running averages using 15 min lags. The time of peak for each tions in neuronal activity with a characteristic peak around mid-day experiment was determined by visual inspection of a plot of 2 hr (CT 7) (Gillette and Prosser, 1988); measurement of time of peak running averages for the symmetrically highest point. A characterisprovides an accurate assessment of circadian phase (Gillette et al., tic pattern of change, such that activity was low during subjective 1995). Treatments were applied to the bath of the brain slice chamnight and peaked mid-day near circadian time 7 (CT 7, 7 hr after ber under static bath conditions. Treatments included the specific the onset of light in the donor colony), was observed in vehicle-PKG inhibitor, KT5823 (1.0 M), or ␣ODNs (10 M) designed to treated control slices. Phase shift or, in some cases, the presence test for PKG specificity. For continuous ␣ODN treatment, media or absence of a rhythm was determined by comparing the mean containing ␣ODN was continuously perfused through the chamber, time of peak from treatment groups to vehicle-treated controls. and the flow rate was reduced to ‫2ف‬ ml/hr. Treatment times ranged Certain recordings were performed with the experimenter blind to from 0.25 to 58 hr. the treatment conditions.
Isoform-Specific PKG Antisera
Quantitative Real-Time RT-PCR Polyclonal antisera were raised in rabbit to synthetic peptides choSingle 500 m SCN reduced slices were collected on dry ice immedisen to confer specificity and antigenicity for each PKG isoform. ately after treatment. Samples were placed in 1 ml TRIzol reagent Antisera were generated against the following peptide encoding (GIBCO BRL/Invitrogen, Carsbad, CA). RNA isolation was performed residues: PKG-1␣, 51-78 of human PKG-I␣ (accession number according to the manufacturer's protocol. Concentration and purity D45864); PKG-I␤, 51-76 of human PKG-I␤ (accession number S05702); of the RNA was determined by UV spectrophotometry. Reverse and PKG-II, 1-29 of rat PKG-II (accession number CAA85284). Peptranscription was performed in duplicate with 500 ng of total RNA tides were synthesized at the Protein Sciences Facility (University in a volume of 10 l, and 200 ng of random hexamers were added. of Illinois Biotechnology Center). Isoform specificity was confirmed Samples were heat denatured at 75ЊC for 10 min and quick chilled on by testing the immunoreactivity of each antiserum to all three PKG ice to minimize secondary structure present in the RNA. Invitrogen isoforms. PKG-I␣ (bovine, recombinant Spodoptera frugiperda) was Superscript II reverse transcriptase (200 U) was added along with purchased from Calbiochem (San Diego, CA). PKG-I␤ (bovine, rebuffer and 500 M dNTP mix (final reaction concentration) to bring combinant baculovirus) was purchased from Alexis Biochemicals the total sample volume to 20 l. Reactions were incubated for 1 hr (San Diego, CA). pCMVneo PKG-II cDNA (a gift from Dr. Michael at 42ЊC followed by a 10 min deactivation at 92ЊC. Samples were Uhler, University of Michigan) was overexpressed in HEK cells by then diluted to 100 l with nuclease-free water and stored at Ϫ20ЊC transient transfection using Mirus trans-it LTI transfection reagent until use. (Madison, WI) according to the manufacturer's instructions. AddiPrimers were chosen using Primer Express 2.0 software (Applied tionally, specific tissues known to express or not express PKG isoBiosystems, Foster City, CA). A BLASTN search was then performed forms were used to verify the isoform specificity of our antisera against GenBank to ensure that all primers were unique to the gene (data not shown). Finally, preabsorption with the synthetic peptide of interest. To avoid amplification from genomic DNA contamination, against which each antibody was generated resulted in the loss of primer sets were designed to amplify across an intron/exon junction. the band for each respective PKG band (data not shown).
Bmal1 primers were as follows: forward, TCTATCCGATGACGAACT GAAACA; reverse, CCCTCGGTCACATCCTACGA. Acidic robosomal Isoform-Specific ␣ODNs protein PO (accession number NM022402) primers were as follows: Isoform-specific ␣ODNs were designed to distinguish between forward, CGTGATGCCCAGGGAAGA; reverse, TCCCACAATGAAG PKG-II (5Ј-CCATGTTGCTCAGGA-3Ј) and PKG-I (5Ј-CCCATGCTCC CATTTTGG. TCCGG-3Ј). The ␣ODN for PKG-I would affect both PKG-I␣ and All reactions were performed on the BioRad iCycler in triplicate PKG-I␤; however, PKG1␣ is not detectable in the SCN (data not with 12.5 l SYBR Green Master Mix (Applied Biosystems, Foster shown). In addition, PKG-II-specific ␣ODN containing one (5Ј-CGAT City, CA), 300 nM forward and reverse primer final concentration, GTTGCTCAGGA-3Ј) or three (5Ј-CGATGATGCTCACGA-3Ј) mis-5 l of diluted RT reaction, and water to a final reaction volume of matched nucleotides or scrambled sequence (5Ј-TCAGTACTGAG 25 l. Initial denature was carried out at 95ЊC for 10 min, followed GCCT-3Ј) were generated for use as controls.
by 50 cycles of 15 s at 95ЊC and 15 s at 60ЊC. Heat disassociation was performed to check for nonspecific signals from SYBR Green and to ensure amplification specificity. Western Blot Hypothalamic brain slices (500 M) containing the paired SCN were qPCR results are represented as a ratio of relative expression levels of the transcript of interest compared to a housekeeping trimmed under a dissecting scope to preserve only the SCN and underlying optic chiasm. These "reduced" slices retain the electrotranscript (acidic ribosomal protein, NM022402) used as a loading control and normalized to the value at CT 0. Relative expression physiological and biochemical properties observed in full-size SCN slices (Gillette and Reppert, 1987) . Slices were equilibrated in the levels were determined by comparing the cycle at which an arbitrary fluorescent threshold (Ct value) was reached to a standard curve for brain slice chamber for at least 2 hr before the initiation of sample collection. Slices removed from the chamber at appropriate circaeach primer set based on known RNA concentration, as described
